DEHP exposure to human neuroblastoma (SH-SY5Y) cells increased ROS production, Nrf2 expression, HO-1 expression and apoptosis, demonstrating that despite upregulation of the Nrf2 pathway by ROS such a response was insufficient to combat ROS production [56]. This evidence concerns the gene NFE2L2 and neuroblastoma.